Effect of tyrosine-derived triblock copolymer compositions on nanosphere self-assembly and drug delivery

Biomacromolecules

Volumn 8, Issue 3, 2007, Pages 998-1003

  Sheihet, Larisa ^a   Piotrowska, Karolina ^a   Dubin, Robert A ^a   Kohn, Joachim ^a   Devore, David ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESAMINOTYROSYL TYROSINE ESTER; HYDROPHOBIC THERAPEUTIC AGENTS;

BLOCK COPOLYMERS; DIALYSIS; HYDROPHOBICITY; NANOSPHERES; OLIGOMERS; POLYETHYLENE GLYCOLS; SELF ASSEMBLY; TUMORS;

DRUG DELIVERY;

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CARBROMAL; COLCHICINE; COPOLYMER; CYTARABINE; DESAMINOTYROSYL TYROSINE ESTER; MACROGOL DERIVATIVE; NANOSPHERE; NOCODAZOLE; PACLITAXEL; RAPAMYCIN; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CALCULATION; CELL KILLING; CHEMICAL INTERACTION; CHEMICAL PARAMETERS; CONTROLLED STUDY; DIALYSIS; DRUG BINDING; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; PH; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; THERMODYNAMICS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYDROGEN-ION CONCENTRATION; MACROMOLECULAR SUBSTANCES; MODELS, CHEMICAL; MOLECULAR WEIGHT; NANOSTRUCTURES; NANOTUBES; PACLITAXEL; POLYETHYLENE GLYCOLS; POLYMERS; STRUCTURE-ACTIVITY RELATIONSHIP; TYROSINE;

EID: 33947674848     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm060860t     Document Type: Article

References (38)

1. Myrdal, P. B.; Yalkowasky, S. H.; Swarbick, J.; Boylan, J. C. Encyclopedia of Pharmaceutical Technology; Marcel Dekker: New York, 2002.
2. Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Eur. J. Cancer 2001, 37, 1590-1598.
3. Potineni, A.; Lynn, D. M.; Langer, R.; Amiji, M. M. J. Controlled Release 2003, 86, 223-234.
4. Opanasopit, P.; Yokoyama, M.; Watanabe, M.; Kawano, K.; Maitani, Y.; Okano, T. Pharm. Res. 2004, 21, 2001-2008.
5. Yokoyama, M.; Opanasopit, P.; Okano, T.; Kawano, K.; Maitani, Y. J. Drug Target 2004, 12, 373-384.
6. Gradishar, W. J.; Tjulandin, S.; Davidson, N.; Shaw, H.; Desai, N.; Bhar, P.; Hawkins, M.; O'Shaughnessy, J. J. Clin. Oncol. 2005, 23, 7794-7803.
7. Torchilin, V. P. Adv. Drug Delivery Rev. 2005, 57, 95-109.
8. Williams, J.; Lansdown, R.; Sweitzer, R.; Romanowski, M.; LaBell, R.; Ramaswami, R.; Unger, E. J Controlled Release 2003, 91, 167-172.
9. Kim, T. Y.; Kim, D. W.; Chung, J. Y.; Shin, S. G.; Kim, S. C.; Heo, D. S.; Kim, N. K.; Bang, Y. J. Clin. Cancer Res. 2004, 10, 3708-3716.
10. Matsumura, Y.; Hamaguchi, T.; Ura, T.; Muro, K.; Yamada, Y.; Shimada, Y.; Shirao, K.; Okusaka, T.; Ueno, H.; Ikeda, M.; Watanabe, N. Br. J. Cancer 2004, 91, 1775-1781.
11. Danson, S.; Ferry, D.; Alakhov, V.; Margison, J.; Kerr, D.; Jowle, D.; Brampton, M.; Halbert, G.; Ranson, M. Br. J. Cancer 2004, 90, 2085-2091.
12. Zhang, L.; Eisenberg, A. Polym. Adv. Technol. 1998, 9, 677-699.
13. Dorr, R. T. Ann. Pharmacother. 1994, 28, 11-14.
14. Torchilin, V. P. J. Controlled Release 2001, 73, 137-172.
15. Haag, R. Angew. Chem., Int. Ed. 2004, 43, 278-282.
16. Greenwald, R. B.; Choe, Y. H.; McGuire, J.; Conover, C. D. Adv. Drug Delivery Rev. 2003, 55, 217-250.
17. Allen, C.; Han, J.; Yu, Y.; Maysinger, D.; Eisenberg, A. J. Controlled Release 2000, 63, 275-286.
18. Liggins, R. T.; D'Amours, S.; Demetrick, J. S.; Machan, L. S.; Burt, H. M. Biomaterials 2000, 21, 1959-1969.
19. Shenoy, D.; Little, S.; Langer, R.; Amiji, M. Pharm. Res. 2005, 22, 2107-2114.
20. Kataoka, K.; Matsumoto, T.; Yokoyama, M.; Okano, T.; Sakurai, Y.; Fukushima, S.; Okamoto, K.; Kwon, G. S. J. Controlled Release 2000, 64, 143-153.
21. Kabanov, A. V.; Batrakova, E. V.; Alakhov, V. Y. Adv. Drug Deliv. Rev. 2002, 54, 759-779.
22. Batrakova, E. V.; Li, S.; Miller, D. W.; Kabanov, A. V. Pharm. Res. 1999, 16, 1366-1372.
23. Xu, Z. K.; Nie, F. Q.; Qu, C.; Wan, L. S.; Wu, J.; Yao, K. Biomaterials 2005, 26, 589-598.
24. Haag, R.; Kratz, F. Angew. Chem., Int. Ed. 2006, 45, 1198-1215.
25. Maeda, H.; Sawa, T.; Konno, T. J. Controlled Release 2001, 74, 47-61.
26. Nagarajan, R.; Ganesh, K. Macromolecules 1989, 22, 4312-4325.
27. Allen, C.; Maysinger, D.; Eisenberg, A. Colloids Surf., B 1999, 16, 3-27.
28. Soo, P. L.; Luo, L.; Maysinger, D.; Eisenberg, A. Langmuir 2002, 18, 9996-10004.
29. Nardin, C.; Bolikal, D.; Kohn, J. Langmuir 2004, 20, 11721-11725.
30. Sheihet, L.; Dubin, R. A.; Devote, D.; Kohn, J. Biomacromolecules 2005, 6, 2726-2731.
31. Morrison, I. D.; Ross, S. Colloidal Dispersions: Suspensions, Emulsions, and Foams; John Wiley and Sons, Inc.: New York, 2002.
32. Jaffe, M.; Ophir, Z.; Collins, G.; Recber, A.; Yoo, S.-u.; Rafalko, J. Polymer 2003, 44, 6033-6042.
33. Jaffe, M.; Pai, V.; Ophir, Z.; Wu, J.; Kohn, J. Polym. Adv. Technol. 2002, 13, 926-937.
34. Gadelle, F.; Koros, W. J.; Schechter, R. S. Macromolecules 1995, 28, 4883-4892.
35. Nagarajan, R.; Maureen, B.; Ruckensteinf, E. Langmuir 1986, 2, 210-215.
36. Van Krevelen, D. W. Properties of Polymers; Elsevier Science B.V.: Amsterdam, The Netherlands, 1997.
37. Desai, N.; Trieu, V.; Yao, Z.; Louie, L.; Ci, S.; Yang, A.; Tao, C.; De, T.; Beals, B.; Dykes, D.; Noker, P.; Yao, R.; Labao, E.; Hawkins, M.; Soon-Shiong, P. Clin. Cancer Res. 2006, 12, 1317-1324.
38. Abraxis Oncology. Abraxane for Injectable Suspensions; Schaumburg, IL, 2005; insert 451031.